Log in
Enquire now
bioMerieux

bioMerieux

bioMérieux develops in vitro products to diagnose infectious diseases, cancer and cardiovascular disease and to detect microorganisms in agri-foods, pharmaceuticals and cosmetics.

OverviewStructured DataIssuesContributors

Contents

biomerieux-usa.com
biomerieux.de
biomerieux.co.jp
biomerieux.fr
biomerieux.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
In-vitro diagnostics (IVD)
In-vitro diagnostics (IVD)
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Health technology
Health technology
Biopharmaceutical
Biopharmaceutical
‌
Biologics
...
Location
Marcy-l'Étoile
Marcy-l'Étoile
France
France
North Carolina
North Carolina
Salt Lake City
Salt Lake City
Tokyo
Tokyo
Durham, North Carolina
Durham, North Carolina
B2X
B2B
B2B
CEO
‌
Stephane Bancel
Founder
‌
Alain Mérieux
‌
Stephane Bancel
AngelList URL
angel.co/company/biomerieux
Pitchbook URL
pitchbook.com/profiles.../53836-75
Parent Organization
‌
Institut Mérieux
Subsidiary
Biofire Diagnostics
Biofire Diagnostics
‌
Organon Teknika Corp.
Legal classification
S.A. (corporation)
S.A. (corporation)
Number of Employees (Ranges)
10,001+
Number of Employees
12,800
Full Address
100, Allée Louis Pasteur, Marcy-l'Étoile, Auvergne-Rhône-Alpes 69280, FR
Founded Date
1963
Competitors
CerTest Biotec
CerTest Biotec
Also Known As
BioMérieux
Patents Assigned (Count)
119
Legal Entity Identifier
549300AK8Y0LBIQ4T071
Wellfound ID
biomerieux
Country
Japan
Japan
France
France
Headquarters
Marcy-l'Étoile
Marcy-l'Étoile

Other attributes

Company Operating Status
Active
Strategic Partnerships
SeouLin Bioscience
SeouLin Bioscience
Invested in
Qvella
Qvella
Wikidata ID
Q2904021

BioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors.

bioMérieux provides diagnostic solutions (reagents, instruments, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the NYSE and Euronext Paris stock exchange.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like bioMerieux

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.